Effects of Myo-inositol in Women With Polycystic Ovary Syndrome

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 26, 2021

Primary Completion Date

October 20, 2023

Study Completion Date

October 20, 2023

Conditions
Polycystic Ovary SyndromeResistance, InsulinGlucose Intolerance
Interventions
DRUG

Myo-inositol

"30 women with polycystic ovary syndrome and insulin resistance or glucose intolerance will used myo-inositol 2g + folic acid 200mcg twice daily for 6 months, having a re-evaluation every 3 months.~Evaluation will be made by transvaginal ultrasound, abdominal ultrasound, inflammatory tests, hormonal tests, glycemic curve with insulin curve, lipid profile, body mass index, evaluation of abdominal and hip circumference."

DRUG

Metformin

"30 women with polycystic ovary syndrome and insulin resistance or glucose intolerance will used metformin 850 mg twice a day for 6 months, having a re-evaluation every 3 months.~Evaluation will be made by transvaginal ultrasound, abdominal ultrasound, inflammatory tests, hormonal tests, glycemic curve with insulin curve, lipid profile, body mass index, evaluation of abdominal and hip circumference."

Trial Locations (2)

05403000

Hospital Das Clinicas - Fmusp, São Paulo

Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT04892186 - Effects of Myo-inositol in Women With Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter